Kezuo Hou

3.7k citations
116 papers · 2.9k indexed · h-index 31
Topics
RNA modifications and cancer (13 papers)Cancer-related molecular mechanisms research (13 papers)Lung Cancer Treatments and Mutations (13 papers)
Journals
Nature CommunicationsSHILAP Revista de lepidopterologíaOncogene

In The Last Decade

Kezuo Hou

114 papers receiving 2.8k citations

Peers

Kezuo Hou
Comparison fields: 5 of 122
  • Molecular Biology 1.9k
  • Cancer Research 910
  • Oncology 909
  • Immunology 551
  • Pulmonary and Respiratory Medicine 408
Replace Xiaofang Che with:
Xiaofang Che China
Amro Aboukameel United States
Jingxuan Pan China
George G. Chen Hong Kong
F. H. Sarkar United States
David Llobet‐Navàs Spain
Lianxin Liu China
Jeong‐Seok Nam South Korea
Kezuo Hou relative to Xiaofang Che China Xiaofang Che's profile →
Citations per field
00.5×1.5×
Xiaofang Che · 1×
Citations per year

Countries citing papers authored by Kezuo Hou

Since Specialization
Citations

This map shows the geographic impact of Kezuo Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kezuo Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kezuo Hou more than expected).

Fields of papers citing papers by Kezuo Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kezuo Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kezuo Hou. The network helps show where Kezuo Hou may publish in the future.

Co-authorship network of co-authors of Kezuo Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Kezuo Hou. A scholar is included among the top collaborators of Kezuo Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kezuo Hou. Kezuo Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 28
3 41
4 11
5 6
6 46
7 19
8 50
9 29
10 19
11 46
12 24
13 10
14 3
15 75
16 1
17 36
18 40
19 141
20
Inhibition effect of eethanol extract of Chinese toad venom on H22 ascites and solid tumors and its toxicity in mice
1

About Kezuo Hou

Kezuo Hou is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 116 papers that have together received 2.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (13 papers) and Lung Cancer Treatments and Mutations (13 papers). The work is most often cited by research in Cancer Research (910 citations), Oncology (909 citations) and Molecular Biology (1.9k citations). Kezuo Hou has collaborated with scholars based in China, United States and Saint Kitts and Nevis. Frequent co-authors include Xiujuan Qu, Yunpeng Liu, Xiaofang Che, Yibo Fan, Ling Xu, Ce Li, Yuee Teng, Jinglei Qu, Xuejun Hu and Zhi Li. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026